|Cooperation Models||Partners/ Investors|
|Third Party Recommendation|
|Third Party Verification||Authenticated|
CPT technology is an innovation in the peptide manufacturing process - Solid Phase Peptide Synthesis (SPPS), which has been used for more than 40 years. The peptide pharmaceutical market is currently the largest submarket for the peptide industry. At present, the global market for peptide drugs has exceeded 20 billion US dollars, accounting for about 2% of all pharmaceutical products, maintaining a growth rate of about 10%. With the expiration of patents for multiple peptide heavy products, generic drugs now have a chance. Compared with the international market, China's peptide drug market is in a period of rapid growth. On the one hand, because the market for peptide drugs in China is not mature, the product structure is also different from that of developed countries. On the other hand, factors such as increased aging in China, changes in living habits, and environmental degradation have increased the prevalence of cancer and chronic diseases in China, which has increased the demand for medication. It is predicted that by 2020, the global cosmetic peptide market will reach US$4.1 billion.
In order to maximize the application of our revolutionary technology, we are looking for venture capitalists and partners to realize our vision for future peptide production and accelerate our strategy to open up market.